Determinants of the Establishment of Human Immunodeficiency Virus Type 1 Latency

被引:93
作者
Duverger, Alexandra [1 ]
Jones, Jennifer [1 ]
May, Jori [1 ]
Bibollet-Ruche, Frederic [1 ]
Wagner, Frederic A. [1 ]
Cron, Randall Q. [1 ]
Kutsch, Olaf [1 ]
机构
[1] Univ Alabama Birmingham, Dept Med, BBRB, Div Infect Dis, Birmingham, AL 35294 USA
关键词
LONG TERMINAL REPEAT; CD4(+) T-CELLS; NF-KAPPA-B; ACTIVE ANTIRETROVIRAL THERAPY; TUMOR NECROSIS FACTOR; HIV-1; INFECTION; TRANSCRIPTIONAL ACTIVATION; HISTOGENETIC SUBSETS; VALPROIC ACID; IN-VITRO;
D O I
10.1128/JVI.02058-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Recent research has emphasized the notion that human immunodeficiency virus type 1 (HIV-1) latency is controlled by a restrictive histone code at, or DNA methylation of, the integrated viral promoter (long terminal repeat [LTR]). The present concept of HIV-1 latency has essentially been patterned from the principles of cellular gene regulation. Here we introduce an experimental system that allows for the qualitative and quantitative kinetic study of latency establishment and maintenance at the population level. In this system, we find no evidence that HIV-1 latency establishment is the consequence of downregulation of initial active infection followed by the establishment of a restrictive histone code at the viral LTR. Latent infection was established following integration of the virus in the absence of viral gene expression (silent integration) and was a function of the NF-kappa B activation level in the host cell at the time of infection. In the absence of a role for epigenetic regulation, we demonstrate that transcriptional interference, a mechanism that has recently been suggested to add to the stabilization of HIV-1 latency, is the primary mechanism to govern latency maintenance. These findings provide direct experimental evidence that the high number of viral integration events (>90%) found in actively expressed genes of CD4(+) memory T cells from highly active antiretroviral therapy-suppressed patients represent indeed latent infection events and that transcriptional interference may be the primary mechanism to control HIV-1 latency in vivo. HIV-1 latency may thus not be governed by the principles of cellular gene regulation, and therapeutic strategies to deplete the pool of latently HIV-1-infected cells should be reconsidered.
引用
收藏
页码:3078 / 3093
页数:16
相关论文
共 61 条
  • [11] Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection
    Cavert, W
    Notermans, DW
    Staskus, K
    Wietgrefe, SW
    Zupancic, M
    Gebhard, K
    Henry, K
    Zhang, ZQ
    Mills, R
    McDade, H
    Goudsmit, J
    Danner, SA
    Haase, AT
    [J]. SCIENCE, 1997, 276 (5314) : 960 - 964
  • [12] The kappa B sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth
    Chen, BK
    Feinberg, MB
    Baltimore, D
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (07) : 5495 - 5504
  • [13] Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: Implications for eradication of virus
    Chun, Tae-Wook
    Justement, J. Shawn
    Moir, Susan
    Hallahan, Claire W.
    Maenza, Janine
    Mullins, James I.
    Collier, Ann C.
    Corey, Lawrence
    Fauci, Anthony S.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (12) : 1762 - 1764
  • [14] Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy
    Chun, TW
    Davey, RT
    Ostrowski, M
    Justement, JS
    Engel, D
    Mullins, JI
    Fauci, AS
    [J]. NATURE MEDICINE, 2000, 6 (07) : 757 - 761
  • [15] IN-VIVO FATE OF HIV-1-INFECTED T-CELLS - QUANTITATIVE-ANALYSIS OF THE TRANSITION TO STABLE LATENCY
    CHUN, TW
    FINZI, D
    MARGOLICK, J
    CHADWICK, K
    SCHWARTZ, D
    SILICIANO, RF
    [J]. NATURE MEDICINE, 1995, 1 (12) : 1284 - 1290
  • [16] Quantification of latent tissue reservoirs and total body viral load in HIV-1 Infection
    Chun, TW
    Carruth, L
    Finzi, D
    Shen, XF
    DiGiuseppe, JA
    Taylor, H
    Hermankova, M
    Chadwick, K
    Margolick, J
    Quinn, TC
    Kuo, YH
    Brookmeyer, R
    Zeiger, MA
    BarditchCrovo, P
    Siliciano, RF
    [J]. NATURE, 1997, 387 (6629) : 183 - 188
  • [17] Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines
    Chun, TW
    Engel, D
    Mizell, SB
    Ehler, LA
    Fauci, AS
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (01) : 83 - 91
  • [18] Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
    Chun, TW
    Stuyver, L
    Mizell, SB
    Ehler, LA
    Mican, JAM
    Baseler, M
    Lloyd, AL
    Nowak, MA
    Fauci, AS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) : 13193 - 13197
  • [19] Latent reservoirs of HIV: Obstacles to the eradication of virus
    Chun, TW
    Fauci, AS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) : 10958 - 10961
  • [20] Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy
    Chun, TW
    Engel, D
    Mizell, SB
    Hallahan, CW
    Fischette, M
    Park, S
    Davey, RT
    Dybul, M
    Kovacs, JA
    Metcalf, JA
    Mican, JM
    Berrey, MM
    Corey, L
    Lane, HC
    Fauci, AS
    [J]. NATURE MEDICINE, 1999, 5 (06) : 651 - 655